Abstract

RAS is the founding member of a superfamily of GTPases and regulates signaling pathways involved in cellular growth control. While recent studies have shown that the activation state of RAS can be controlled by lysine ubiquitylation and acetylation, the existence of lysine methylation of the RAS superfamily GTPases remains unexplored. In contrast to acetylation, methylation does not alter the side chain charge and it has been challenging to deduce its impact on protein structure by conventional amino acid substitutions. Herein, we investigate lysine methylation on RAS and RAS-related GTPases. We developed GoMADScan (Go language-based Modification Associated Database Scanner), a new user-friendly application that scans and extracts posttranslationally modified peptides from databases. The GoMADScan search on PhosphoSitePlus databases identified methylation of conserved lysine residues in the core GTPase domain of RAS superfamily GTPases, including residues corresponding to RAS Lys-5, Lys-16, and Lys-117. To follow up on these observations, we immunoprecipitated endogenous RAS from HEK293T cells, conducted mass spectrometric analysis and found that RAS residues, Lys-5 and Lys-147, undergo dimethylation and monomethylation, respectively. Since mutations of Lys-5 have been found in cancers and RASopathies, we set up molecular dynamics (MD) simulations to assess the putative impact of Lys-5 dimethylation on RAS structure. Results from our MD analyses predict that dimethylation of Lys-5 does not significantly alter RAS conformation, suggesting that Lys-5 methylation may alter existing protein interactions or create a docking site to foster new interactions. Taken together, our findings uncover the existence of lysine methylation as a novel posttranslational modification associated with RAS and the RAS superfamily GTPases, and putative impact of Lys-5 dimethylation on RAS structure.

Highlights

  • The small GTPase RAS is a signaling switch, cycling between active GTP- and inactive GDPbound states

  • To explore whether lysine methylation occurs in RAS related proteins by database search, we developed GoMADScan (Go language-based Modification Associated Database Scanner: https://github.com/carushi/GoMADScan)

  • We have identified methylation at Lys-5 and Lys-147 as a novel post-translational modification in endogenous RAS

Read more

Summary

Introduction

The small GTPase RAS is a signaling switch, cycling between active GTP- and inactive GDPbound states. Development of direct inhibitors of RAS has historically proven challenging [11,12,13,14,15], compounds that target a specific oncogenic mutant (KRAS G12C) [16,17,18] are in phase I clinic trials (Clinical Trial number: NCT03600883, NCT03785249). While these inhibitors appear quite promising, they target one out of many possible oncogenic RAS mutants. Understanding novel mechanisms of RAS regulation may prove helpful in identifying new therapeutic approaches for targeting RAS-driven tumors and developmental disorders

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.